Update on seeking corporate partners? Maintain o
Post# of 72440
Maintain ongoing discussions with multiple potential partners. Have signed agreements with some of world's largest biotechs and pharmas.
Presenting or just attending conference?
Presenting
What's the plan for ABSSSI Brilacidin study?
FDA has certain things they want in trials. CTIX thinks some of them are unnecessary, so are negotiating with FDA on this. Want to reach terms for the trial. We've seen even greater possibilities in the anti-inflammatory area.
ABSSSI is very expensive, have budgeted 30 million so far.
DILUTION; DON'T WANT TO FUND TRIALS UNTIL STOCK PRICE RECOVERS.
Benefit of oral Kevetrin is obvious. What has to be done to do this?
Can use IV form with no problem. Have to do toxicology studies on Kevetrin -- try it on healthy volunteers. Won't take long to get oral to same point as IV version.
Parnerships:
CTIX has strict confidentially agreements.
Leo reviews progress of the compounds, same stuff everyone has said through the call.
Safety, efficacy, multiple applications: this is what attracts attention of big pharma.
Stock price doesn't reflect value of company. How are you going to get more investors?
All investors think that price doesn't reflect value. CEO shouldn't comment on stock price, hope that as people become more aware, more will invest.
Are you going to update website?
Yes, will launch soon.